Clinical trial
Impact of a Compliance-Guided Intraoperative Abdominal Wall Closure Decision Strategy on Early Postoperative Respiratory Failure After Large Ventral Hernia Repair Following Preoperative Botulinum Toxin A
NCT07422441 is registered in ClinicalTrials.gov with Swissmed Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of a Compliance-Guided Intraoperative Abdominal Wall Closure Decision Strategy on Early Postoperative Respiratory Failure After Large Ventral Hernia Repair Following Preoperative Botulinum Toxin A
- Lead sponsor
- Swissmed Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 20, 2026
- Completion date
- November 1, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hernia incisional, hernia, ventral, postoperative complications, respiratory insufficiency